Avenue Therapeutics, Inc. (Avenue) has announced the upcoming Annual Meeting of Stockholders to be held virtually on June 24, 2024. Stockholders are invited to attend the meeting online, where they will vote on several key proposals, including the election of six directors, the ratification of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2024, and the approval of an amendment to the Avenue Therapeutics Inc. 2015 Incentive Plan. The amendment proposes an increase in the number of authorized shares issuable under the plan by 5,000,000 shares, extending the plan's term to June 24, 2034, and increasing the annual share limit for awards to non-employee directors. The meeting will also address any other business that may properly come before the...Show More

Avenue Therapeutics, Inc. (Avenue) has announced the upcoming Annual Meeting of Stockholders to be held virtually on June 24, 2024. Stockholders are invited to attend the meeting online, where they will vote on several key proposals, including the election of six directors, the ratification of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2024, and the approval of an amendment to the Avenue Therapeutics Inc. 2015 Incentive Plan. The amendment proposes an increase in the number of authorized shares issuable under the plan by 5,000,000 shares, extending the plan's term to June 24, 2034, and increasing the annual share limit for awards to non-employee directors. The meeting will also address any other business that may properly come before the Annual Meeting or any postponement or adjournment thereof. Stockholders of record as of April 30, 2024, are entitled to vote at the meeting. The company emphasizes the importance of stockholder votes and provides various methods for voting, including online and by mobile device. The meeting will also be an opportunity for stockholders to ask questions.